BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 24636808)

  • 1. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.
    del Campo R; Garriga M; Pérez-Aragón A; Guallarte P; Lamas A; Máiz L; Bayón C; Roy G; Cantón R; Zamora J; Baquero F; Suárez L
    J Cyst Fibros; 2014 Dec; 13(6):716-22. PubMed ID: 24636808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic supplementation in children with cystic fibrosis-a systematic review.
    Ananthan A; Balasubramanian H; Rao S; Patole S
    Eur J Pediatr; 2016 Oct; 175(10):1255-66. PubMed ID: 27576473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.
    Kong XJ; Liu K; Zhuang P; Tian R; Liu S; Clairmont C; Lin X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Yu Z; Shen C; Cui X; Cao H; Du T; Wan G; Cao X
    Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1508-1520. PubMed ID: 34115318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of
    Martí M; Spreckels JE; Ranasinghe PD; Wejryd E; Marchini G; Sverremark-Ekström E; Jenmalm MC; Abrahamsson T
    Cell Rep Med; 2021 Mar; 2(3):100206. PubMed ID: 33763652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crying Time and RORγ/FOXP3 Expression in Lactobacillus reuteri DSM17938-Treated Infants with Colic: A Randomized Trial.
    Savino F; Garro M; Montanari P; Galliano I; Bergallo M
    J Pediatr; 2018 Jan; 192():171-177.e1. PubMed ID: 28969887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus reuteri ATCC55730 in cystic fibrosis.
    Di Nardo G; Oliva S; Menichella A; Pistelli R; De Biase RV; Patriarchi F; Cucchiara S; Stronati L
    J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):81-6. PubMed ID: 24121143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial.
    Bruzzese E; Callegari ML; Raia V; Viscovo S; Scotto R; Ferrari S; Morelli L; Buccigrossi V; Lo Vecchio A; Ruberto E; Guarino A
    PLoS One; 2014; 9(2):e87796. PubMed ID: 24586292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics in cystic fibrosis patients: A double blind crossover placebo controlled study: Pilot study from the ESPGHAN Working Group on Pancreas/CF.
    Van Biervliet S; Hauser B; Verhulst S; Stepman H; Delanghe J; Warzee JP; Pot B; Vandewiele T; Wilschanski M
    Clin Nutr ESPEN; 2018 Oct; 27():59-65. PubMed ID: 30144894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis.
    Husain S; Allotey J; Drymoussi Z; Wilks M; Fernandez-Felix BM; Whiley A; Dodds J; Thangaratinam S; McCourt C; Prosdocimi EM; Wade WG; de Tejada BM; Zamora J; Khan K; Millar M
    BJOG; 2020 Jan; 127(2):275-284. PubMed ID: 30932317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Oral Probiotic
    Yang S; Reid G; Challis JRG; Gloor GB; Asztalos E; Money D; Seney S; Bocking AD
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Lactobacillus reuteri colonization on gut microbiota, inflammation, and crying time in infant colic.
    Nation ML; Dunne EM; Joseph SJ; Mensah FK; Sung V; Satzke C; Tang MLK
    Sci Rep; 2017 Nov; 7(1):15047. PubMed ID: 29118383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial.
    Flichy-Fernández AJ; Ata-Ali J; Alegre-Domingo T; Candel-Martí E; Ata-Ali F; Palacio JR; Peñarrocha-Diago M
    J Periodontal Res; 2015 Dec; 50(6):775-85. PubMed ID: 25712760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of probiotic
    Rahayu ES; Mariyatun M; Putri Manurung NE; Hasan PN; Therdtatha P; Mishima R; Komalasari H; Mahfuzah NA; Pamungkaningtyas FH; Yoga WK; Nurfiana DA; Liwan SY; Juffrie M; Nugroho AE; Utami T
    World J Gastroenterol; 2021 Jan; 27(1):107-128. PubMed ID: 33505154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotic supplementation in systemic nickel allergy syndrome patients: study of its effects on lactic acid bacteria population and on clinical symptoms.
    Randazzo CL; Pino A; Ricciardi L; Romano C; Comito D; Arena E; Saitta S; Caggia C
    J Appl Microbiol; 2015 Jan; 118(1):202-11. PubMed ID: 25363062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial.
    Hsieh MC; Tsai WH; Jheng YP; Su SL; Wang SY; Lin CC; Chen YH; Chang WW
    Sci Rep; 2018 Nov; 8(1):16791. PubMed ID: 30429496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
    Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
    Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial.
    Romani Vestman N; Chen T; Lif Holgerson P; Öhman C; Johansson I
    PLoS One; 2015; 10(5):e0125812. PubMed ID: 25946126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus reuteri derived from horse alleviates Escherichia coli-induced diarrhea by modulating gut microbiota.
    Wang D; Zeng J; Wujin C; Ullah Q; Su Z
    Microb Pathog; 2024 Mar; 188():106541. PubMed ID: 38224920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR).
    Tenorio-Jiménez C; Martínez-Ramírez MJ; Tercero-Lozano M; Arraiza-Irigoyen C; Del Castillo-Codes I; Olza J; Plaza-Díaz J; Fontana L; Migueles JH; Olivares M; Gil Á; Gomez-Llorente C
    BMC Complement Altern Med; 2018 Nov; 18(1):306. PubMed ID: 30453950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study.
    Francavilla R; Polimeno L; Demichina A; Maurogiovanni G; Principi B; Scaccianoce G; Ierardi E; Russo F; Riezzo G; Di Leo A; Cavallo L; Francavilla A; Versalovic J
    J Clin Gastroenterol; 2014; 48(5):407-13. PubMed ID: 24296423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.